文献速递糖尿病

对以胰岛素分泌缺陷和胰岛素敏感性测量作为妊娠期糖尿病精准医学方法的评述

A critique of measurement of defective insulin secretion and insulin sensitivity as a precision approach to gestational diabetes.
PubMed 文献 · Diabetologia · 2024-12-02

该观察性研究纳入1308例有妊娠期糖尿病(GDM)危险因素的孕妇,在九个医院站点行75g口服葡萄糖耐量试验(OGTT),采用增强标本处理测定胰岛素分泌与敏感性指数,并按HOMA2-S和HOMA2-B将GDM分为胰岛素抵抗型、胰岛素分泌不足型、两者兼有或两者均无型,评估其与妊娠结局的关联。结果显示,HOMA2-S和HOMA2-B对妊娠结局预测价值弱,但识别出一个新的GDM亚组,其特征为孤立性餐后胰岛素敏感性缺陷。

要点

  • 增强标本处理下,1027/1308(78.5%)为血糖正常,281/1308(21.5%)诊断为GDM。
  • GDM中胰岛素抵抗型135/281(48.0%)、胰岛素分泌不足型73/281(26.0%)、两者兼有2/281(0.7%)、两者均无71/281(25.3%)。
  • HOMA2-B和HOMA2-S对妊娠结局预测价值弱,多数GDM亚组妊娠结局与血糖正常妇女相当。

核心结论

  • 使用HOMA2-S和HOMA2-B对GDM进行精准分型不能提供有用的诊断或预后信息,但区分出一个以孤立性餐后胰岛素敏感性缺陷为特征的新GDM亚组。

研究设计与样本

  • 观察性研究,纳入1308例有一个或多个GDM危险因素、在九个医院站点之一行75g OGTT的孕妇。
  • 采集标本用标准与增强程序测定血糖、HbA1c和胰岛素,GDM诊断与管理遵循美国国家卫生与临床优化研究所(NICE)指南。
  • 按HOMA2-S低于血糖正常人群第25百分位定义为胰岛素抵抗型GDM,HOMA2-B低于第25百分位定义为胰岛素分泌不足型GDM,并分为两者兼有或两者均无。
  • 采用逻辑回归评估与妊娠结局的关联。

主要发现

  • 增强标本处理下,1027/1308(78.5%)为血糖正常,281/1308(21.5%)分类为GDM。
  • GDM组中,135/281(48.0%)为胰岛素抵抗型,73/281(26.0%)为胰岛素分泌不足型,2/281(0.7%)为两者兼有。
  • 意外发现71例(25.3%)GDM患者HOMA2-S和HOMA2-B均≥第25百分位(GDM-两者均无),该新亚组空腹状态相对胰岛素敏感但负荷后出现明显高血糖和高胰岛素血症。
  • 多数GDM亚组的妊娠结局与血糖正常妇女相当,HOMA2-B和HOMA2-S对妊娠结局预测价值弱。
  • 母亲BMI预测的结局数量与HOMA2-S相似,提示加入HOMA2-S无额外预测价值;使用不同指数和标准标本处理技术获得相似结果。

关键数值与推荐

  • 胰岛素抵抗型GDM定义为HOMA2-S低于血糖正常人群第25百分位。
  • 胰岛素分泌不足型GDM定义为HOMA2-B低于血糖正常人群第25百分位。
  • GDM-两者均无定义为HOMA2-S和HOMA2-B均≥第25百分位。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Precision medicine approaches to gestational diabetes mellitus (GDM) have categorised patients according to disease pathophysiology (insulin resistance, insulin insufficiency or both), and demonstrated associations with clinical outcomes. We aimed to assess whether using enhanced processing to determine indices of insulin secretion and sensitivity is analytically robust, reproducible in a different population, and useful diagnostically and prognostically in clinical practice. METHODS: A total of 1308 pregnant women with one or more risk factors for GDM who underwent a 75 g OGTT at one of nine hospital sites were recruited to this observational study. Specimens were collected for determination of glucose levels using standard and enhanced procedures, HbA1c and insulin analysis. GDM diagnosis and management followed National Institute for Health and Care Excellence guidance. We categorised women into pathophysiological subtypes: insulin-resistant GDM (HOMA2-S < 25th centile of the population with normal glucose tolerance [NGT]), insulin-insufficient GDM (HOMA2-B < 25th centile), both or neither. We assessed associations with pregnancy outcomes using logistic regression. RESULTS: Using enhanced specimen handling, 1027/1308 (78.5%) women had NGT, with 281/1308 (21.5%) being classified as having GDM. Of this group, 135/281 (48.0%) had insulin-resistant GDM, 73/281 (26.0%) had insulin-insufficient GDM and 2/281 (0.7%) had both insulin-resistant and insulin-insufficient GDM. Unexpectedly, 71 patients (25.3%) had GDM with both HOMA2-S and HOMA2-B ≥ 25th centile (GDM-neither). This novel subgroup appeared to be relatively insulin-sensitive in the fasting state but developed marked post-load hyperglycaemia and hyperinsulinaemia, suggesting an isolated postprandial defect in insulin sensitivity that was not captured by HOMA2-B or HOMA2-S. Women within most GDM subgroups had comparable pregnancy outcomes to those of normoglycaemic women, and HOMA2-B and HOMA2-S were weak predictors of pregnancy outcomes. Maternal BMI predicted a similar number of outcomes to HOMA2-S, suggesting that there was no additional predictive value in adding HOMA2-S. Similar findings were obtained when using different indices and standard specimen handling techniques. CONCLUSIONS/INTERPRETATION: Precision categorisation of GDM using HOMA2-S and HOMA2-B does not provide useful diagnostic or prognostic information, but did distinguish a novel subgroup of patients with GDM, characterised by an isolated postprandial defect in insulin sensitivity.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Jones DL, Kusinski LC, Gillies C, et al. A critique of measurement of defective insulin secretion and insulin sensitivity as a precision approach to gestational diabetes. Diabetologia. 2024. PMID: 39621104. doi:10.1007/s00125-024-06334-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。